United States Artificial Organs and Bionics Market Size, Share, By Product Type (Artificial Organs and Bionic), By Technology (Mechanical, Electronic), United States Artificial Organs and Bionics Market Size Insights, Industry Trend, Forecasts to 2035

United States Artificial Organs and Bionics Market Size Insights Forecasts to 2035

• United States Artificial Organs and Bionics Market Size 2024: USD 13104.7 Mn
• United States Artificial Organs and Bionics Market Size 2035:  USD 29119.3 Mn
• United States Artificial Organs and Bionics Market Size CAGR 2024: 7.53%
• United States Artificial Organs and Bionics Market Size Segments: Product Type and Technology

In the United States, the artificial organs and bionics market is comprised of a variety of sophisticated medical devices that restore or replace the functioning of non-functional or absent organs and body parts by means of high-tech biomedical engineering, electronics, and biocompatible materials. Technologies have been invented that imitate body functions that are normally done by the body, which includes heart pumps, filtration of kidneys through dialysis, and devices for hearing and vision such as cochlear and retinal implants, as well as bionic limbs for mobility. In this way, patient survival, independence, and quality of life are all improved.

In August 2025, the BiVACOR's Total Artificial Heart was declared by the FDA to be a part of the Total Product Life Cycle Advisory Program, which turn, fast-tracked the whole regulatory process for market approval. SynCardia Systems got the FDA green signal for a compact driver-modulation unit for its temporary Total Artificial Heart, which not only made it portable but also allowed patients to stay out of the hospital while waiting for a transplant.

The National Institute of Biomedical Imaging and Bioengineering (NIBIB), which belongs to National Institutes of Health (NIH) supports the research work intended for artificial organs, bionic systems, implantable bioelectronics, and other advanced prosthetic devices with a view to enhancing health outcomes of patients.

The future prospects in the U.S. market for artificial organs and bionics will be dominated by the rapid growth of organ shortages, an increasing elderly population, and the introduction of new products such as 3D bio printing, AI-integrated bionics, and devices that are totally implantable, along with the continuous clinical uptake supported by reimbursement and research funding that is favorable.

Market Dynamics of the United States Artificial Organs and Bionics Market Size:

The United States Artificial Organs and Bionics Market Size is driven by the increasing number of chronic disease cases, the growing shortage of organ transplants, the geriatric population, the developments in biomedical engineering, the support for R&D, and the facilitative FDA regulatory pathways that invite the rapid adoption of new implantable and bionic devices.

The United States Artificial Organs and Bionics Market Size is restrained by the exorbitant costs associated with the devices and procedures, inadequate reimbursement coverage, complicated regulatory approvals, surgical risks, and prolonged development timelines for advanced implantable technologies.

The future of United States artificial organs and bionic services market is bright by the unceasing progress in technology, the rising number of organ failures, the availability of research funds, the presence of regulatory support, the increasing acceptance of AI-powered bionics, and the heightened demand for implantable medical devices that can save lives.

Market Segmentation

The United States Artificial Organs and Bionics Market Size share is classified into phase type and service.

By Phase Type:

The United States Artificial Organs and Bionics Market Size is divided by product type into artificial organs and bionic. Among these, the Bionic segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The bionic part is leading the way and becoming the main focus for the technology entering clinics at a quick pace, and the technology is getting more and more accepted in the clinics. Cochlear implants and bionic limbs are examples of devices that are widely and successfully used, being beneficial to the users' daily lives and overall health.

By Service:

The United States Artificial Organs and Bionics Market Size is divided by technology into mechanical and electronic. Among these, the electronic segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The electronic technology segment is the major contributor to the United States market for artificial organs and bionics, owing to the extensive applications in cochlear implants, bionic limbs, neurostimulators, and vision systems, which are being pushed by quick improvements in sensors, AI integration, and implantable electronics.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the United States Artificial Organs and Bionics Market Size, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

Top Key Companies in United States Artificial Organs and Bionics Market Size:

• ABIOMED
• Berlin Heart
• Zimmer Biomet
• Boston Scientific Corporation
• Cochlear Ltd.
• Edwards Lifesciences Corporation
• Ekso Bionics
• Medtronic
• Jarvik Heart, Inc
• SynCardia Systems, LLC
• Others

Recent Developments in United States Artificial Organs and Bionics Market Size:

• In April 2024, United Therapeutics Corporation announced the first successful transplant of a UThymoKidney into a living person.

• In October 2025, Beta Bionics, Inc. announced the launch of a new integration: ILet Bionic Pancreas with Abbott's FreeStyle LIbre 3 Plus sensor. This integration allows users to manage their diabetes, reducing their burden.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States Artificial Organs and Bionics Market Size based on the below-mentioned segments:

United States Artificial Organs and Bionics Market Size, By Product Type

• Artificial Organs
• Bionic

United States Artificial Organs and Bionics Market Size, By Technology

• Mechanical
• Electronic
• Others